Filing Details

Accession Number:
0001209191-10-016615
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-12 12:00:00
Reporting Period:
2010-03-10
Filing Date:
2010-03-12
Accepted Time:
2010-03-12 16:12:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
887359 Aastrom Biosciences Inc ASTM Biological Products, (No Disgnostic Substances) (2836) 943096597
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1194712 Jr W George Dunbar P.o. Box 376
Ann Arbor MI 48106
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-03-10 9,000 $1.56 12,750 No 4 P Indirect By the George & Lucy Dunbar Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By the George & Lucy Dunbar Trust
Footnotes
  1. The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.55 to $1.56, inclusive. The reporting person undertakes to provide Aastrom Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).
  2. Reflects a 1-for-8 reverse stock split which became effective on February 18, 2010.
  3. These shares are held in a trust for the benefit of the reporting person's children. The reporting person and the reporting person's spouse are trustees of the trust. These shares were previously reported as direct holdings in error. The filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.